Sanofi 2010 AR2
The report outlines Sanofi-aventis' strategic and financial performance for the fiscal year 2010, highlighting its transition into a diversified global healthcare leader. Key achievements include the expansion of its six growth platforms—Emerging Markets, Human Vaccines, Consumer Healthcare, Diabetes, Innovative Products, and Animal Health—which accounted for 54% of total sales. The company also advanced its R&D model, initiated 37 operations including 9 acquisitions, and established the Sanofi Espoir Foundation to reduce global healthcare inequalities. Additionally, Sanofi-aventis made progress in its Corporate Social Responsibility (CSR) agenda, focusing on patient needs, ethics, diversity, and reducing its carbon footprint.
Company: Sanofi
Sector: Health Care
Country: France
Year: 2010
Type: AR2
Pages: 56
Back to company
Sanofi
Annual Review
The report outlines Sanofi-aventis' strategic and financial performance for the fiscal year 2010, highlighting its transition into a diversified global healthcare leader. Key achievements include the expansion of its six growth platforms—Emerging Markets, Human Vaccines, Consumer Healthcare, Diabetes, Innovative Products, and Animal Health—which accounted for 54% of total sales. The company also advanced its R&D model, initiated 37 operations including 9 acquisitions, and established the Sanofi Espoir Foundation to reduce global healthcare inequalities. Additionally, Sanofi-aventis made progress in its Corporate Social Responsibility (CSR) agenda, focusing on patient needs, ethics, diversity, and reducing its carbon footprint.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2010
Reporting Period
Jan 1, 2010 - Dec 31, 2010
Fiscal Year
2010
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees